German HTA Blueprint Could Be Imposed On Greece
This article was originally published in The Pink Sheet Daily
Germany’s role in preparing a health reform agreement between Greece and the World Health Organization may lead to a G-BA/IQWiG-style HTA process being introduced in the Hellenic Republic.
You may also be interested in...
A new leadership team at EMA to be unveiled in September; the death of Pierre Fabre leads to management restructuring at France's third largest pharma; Reinhardt to review strategy as he replaces Vasella at the Swiss multinational, Novartis; and more…
Greece has slashed its pharmaceutical budget in half by price cuts and withholding payments, but it is now turning to generics to fulfill its citizens’ health care needs.
Germany’s powerful health care watchdog G-BA, in its first full opinion on early added benefit assessment of medicines, says the process is fair and promotes real drug innovation, in sharp contrast to the biopharma industry which maintains it is a cost-cutting tool wielded by health insurance funds.